JVS-100: Phase II start

Next quarter, Juventas will begin a Phase II trial to evaluate JVS-100 delivered with the Helical Infusion System from BioCardia Inc. (San Carlos, Calif.) in adults. BioCardia's Helical Infusion Sys...